All Stories

  1. Cluster-Based Immunization Patterns in Diabetes Mellitus: Insights for Personalized Preventive Care
  2. 1H and 31P MRS Interleaved With High Time Resolution Reveals Closely Matching Creatine CH₂ and PCr Dynamics During Exercise
  3. Association of fetal FTO gene variants with maternal postload glucose levels in pregnancy
  4. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
  5. Preexisting Diabetes and Pregnancy: An Endocrine Society and European Society of Endocrinology Joint Clinical Practice Guideline
  6. Bariatric surgery promotes recruitment of brown fat linked to alterations in the gut microbiota
  7. Effectiveness of the Dual GIP/GLP1-Agonist Tirzepatide in 2 Cases of Alström Syndrome, a Rare Obesity Syndrome
  8. A direct effect of the hematocrit on blood glucose: Evidence from hypoxia- and erythropoietin-treated mice
  9. Health Status and Patients’ Satisfaction on the Long Term after Metabolic/Bariatric Surgery
  10. Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings
  11. Comparing Bioelectrical Impedance Analysis, Air Displacement Plethysmography, and Dual-Energy X-Ray Absorptiometry for Body Composition in Pediatric Obesity
  12. The effects of gender-affirming hormone therapy on myocardial, hepatic, pancreatic lipid content, body fat distribution and other cardiometabolic risk factors: A magnetic resonance-based study in transgender individuals
  13. Incidence of Prediabetes and Diabetes in a European Longitudinal General Population Cohort and Its Associated Factors—Results From the Austrian LEAD Study
  14. What all physicians should know about women’s health: a Delphi study
  15. Socioeconomic Gender Variables Impact the Association between Hypertension and Chronic Health Issues: Cross-Sectional Study
  16. Investigating a New Way to Assess Metabolic Risk in Pregnant Females with Prior RYGB Surgery
  17. The Effects of Caloric Restriction and Clinical Psychological Intervention on the Interplay of Gut Microbial Composition and Stress in Women
  18. Unraveling cradle-to-grave disease trajectories from multilayer comorbidity networks
  19. Role of sex and gender-related variables in development of metabolic syndrome: A prospective cohort study
  20. Putting person-centred psychosocial diabetes care into practice: two psychosocial care pathways based on outcome preferences of people with diabetes and healthcare professionals
  21. Tracking chronic diseases via mobile health applications: Which user experience aspects are key? (Preprint)
  22. Sex-Related Disparities in Prescription Patterns of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes and Heart Failure
  23. Diabetes incidence in Austria: The role of famines on diabetes and related NCDs
  24. The Interplay of Adipokines, Body Composition and Glucose Homeostasis in Pregnant Women with a History of RYGB Operation
  25. Age and Sex Determine Electrocardiogram Parameters in the Octodon degus
  26. Excretion of glucose analogue with SGLT2 affinity predicts response effectiveness to sodium glucose transporter 2 inhibitors in patients with type 2 diabetes mellitus
  27. Correction to: Sex differences in type 2 diabetes
  28. Systematic population-wide ecological analysis of regional variability in disease prevalence
  29. Magnesium in Kidney Function and Disease—Implications for Aging and Sex—A Narrative Review
  30. Sex differences in type 2 diabetes
  31. Geschlechtsspezifische Aspekte bei Prädiabetes und Diabetes mellitus – klinische Empfehlungen (Update 2023)
  32. Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study
  33. Effects of gender-affirming hormone therapy on cardiovascular risk factors focusing on glucose metabolism in an Austrian transgender cohort
  34. Vitamin D3 Supplementation in Overweight/Obese Pregnant Women: No Effects on the Maternal or Fetal Lipid Profile and Body Fat Distribution—A Secondary Analysis of the Multicentric, Randomized, Controlled Vitamin D and Lifestyle for Gestational Diabetes...
  35. The Weak Relationship between Vitamin D Compounds and Glucose Homeostasis Measures in Pregnant Women with Obesity: An Exploratory Sub-Analysis of the DALI Study
  36. Stress-testing the resilience of the Austrian healthcare system using agent-based simulation
  37. Biomarkers Predictive for In-Hospital Mortality in Patients with Diabetes Mellitus and Prediabetes Hospitalized for COVID-19 in Austria: An Analysis of COVID-19 in Diabetes Registry
  38. HbA1c and Glucose Management Indicator Discordance Associated with Obesity and Type 2 Diabetes in Intermittent Scanning Glucose Monitoring System
  39. Evaluation of a bariatric monitoring pass for primary care physicians
  40. Angiotensin‐converting enzyme 2 and transmembrane protease serine 2 in female and male patients with end‐stage kidney disease
  41. Authors’ Reply to: Using Caution When Interpreting Gender-Based Relative Risk. Comment on “The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis”
  42. Sex Differences in Clinical Characteristics and Outcomes of Patients with SARS-CoV-2-Infection Admitted to Intensive Care Units in Austria
  43. Neurotensin and Adverse Cardiovascular Outcomes in Patients Undergoing Percutaneous Coronary Intervention
  44. Cardiovascular health through a sex and gender lens in six South Asian countries: Findings from the WHO STEPS surveillance
  45. Authors’ Reply to: Using Caution When Interpreting Gender-Based Relative Risk. Comment on “The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis” (Preprint)
  46. Sex and Gender Influence on Cardiovascular Health in Sub-Saharan Africa: Findings from Ghana, Gambia, Mali, Guinea, and Botswana
  47. Glypican-4 in pregnancy and its relation to glucose metabolism, insulin resistance and gestational diabetes mellitus status
  48. Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
  49. COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age—Propensity Score-Matched Analysis of Austrian National Public Health Institute Data
  50. Does diabetes mellitus mitigate the gender gap in COVID-19 mortality?
  51. Short Term Caloric Restriction and Biofeedback Enhance Psychological Wellbeing and Reduce Overweight in Healthy Women
  52. Glucose intolerance in aging is mediated by the Gpcpd1-GPC metabolic axis
  53. Active Brown Adipose Tissue is Associated With a Healthier Metabolic Phenotype in Obesity
  54. Sex-Specific Effects of Vitamin D Status on the Metabolic Profile in Prediabetic Subjects
  55. The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis
  56. Characterization of endogenous bile acid composition in individuals with cold-activated brown adipose tissue
  57. Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years
  58. Sex, rurality and socioeconomical status in Spanish centennial population (2017)
  59. Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality
  60. Sex differences in brown adipose tissue activity and cold-induced thermogenesis
  61. Increase in testosterone levels is related to a lower risk of conversion of prediabetes to manifest diabetes in prediabetic males
  62. Data-driven identification of complex disease phenotypes
  63. Project “Backtoclinic I”: An overview on the state of care of adult PKU patients in Austria
  64. Diabetes und Schwangerschaft
  65. Risk of Typical Diabetes-Associated Complications in Different Clusters of Diabetic Patients: Analysis of Nine Risk Factors
  66. Diabetes Mellitus is Associated with a Higher Relative Risk for Parkinson’s Disease in Women than in Men
  67. Comparison of Bioelectrical Impedance-Based Methods on Body Composition in Young Patients with Obesity
  68. Sex-Related Differences in Drugs with Anti-Inflammatory Properties
  69. Sex- and Gender-Based Pharmacological Response to Drugs
  70. The Effect of Cardiovascular Comorbidities on Women Compared to Men: Longitudinal Retrospective Analysis (Preprint)
  71. Combined exenatide and dapagliflozin has no additive effects on reduction of hepatocellular lipids despite better glycaemic control in patients with t...
  72. Biological and Psychological Stress Correlates Are Linked to Glucose Metabolism, Obesity, and Gender Roles in Women
  73. Oral Contraceptive Intake and Iodine Status in Young Women
  74. Precision Medicine for the Management of Therapy Refractory Colorectal Cancer
  75. COVID‐19 fatality prediction in people with diabetes and prediabetes using a simple score upon hospital admission
  76. Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers
  77. HbA1c during early pregnancy reflects beta-cell dysfunction in women developing GDM
  78. CTRP-1 levels are related to insulin resistance in pregnancy and gestational diabetes mellitus
  79. Do Women with Diabetes Need More Intensive Action for Cardiovascular Reduction than Men with Diabetes?
  80. Performance of early pregnancy HbA1c for predicting gestational diabetes mellitus and adverse pregnancy outcomes in obese European women
  81. Measurements of Plasma-Free Metanephrines by Immunoassay Versus Urinary Metanephrines and Catecholamines by Liquid Chromatography with Amperometric Detection for the Diagnosis of Pheochromocytoma/Paraganglioma
  82. How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data
  83. Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men
  84. Sex-specific trends in smoking prevalence over seven years in different Austrian populations: results of a time-series cross-sectional analysis
  85. Muscle‐Specific Relation of Acetylcarnitine and Intramyocellular Lipids to Chronic Hyperglycemia: A Pilot 3‐T 1H MRS Study
  86. Secretagogin is Related to Insulin Secretion but Unrelated to Gestational Diabetes Mellitus Status in Pregnancy
  87. Less sedentary time is associated with a more favourable glucose-insulin axis in obese pregnant women—a secondary analysis of the DALI study
  88. Positioning sulphonylureas in a modern treatment algorithm for patients with type 2 diabetes: Expert opinion from a European consensus panel
  89. Increased ATP synthesis might counteract hepatic lipid accumulation in acromegaly
  90. Temporal relationships between maternal metabolic parameters with neonatal adiposity in women with obesity differ by neonatal sex: Secondary analysis of the DALI study
  91. Marked differences in prediabetes‐ and diabetes‐associated comorbidities between men and women—Epidemiological results from a general population‐based cohort aged 6‐80 years—The LEAD (Lung, hEart, sociAl, boDy) study
  92. Cold-mediated regulation of systemic retinol transport controls adipose tissue browning
  93. How Specialist Aftercare Impacts Long-Term Readmission Risks in Elderly Patients With Metabolic, Cardiac, and Chronic Obstructive Pulmonary Diseases: Cohort Study Using Administrative Data (Preprint)
  94. Bariatric Surgery Impacts Levels of Serum Lipids during Pregnancy
  95. Response to: ‘Association between osteoporosis and statin therapy: the story continues’ by Burden and Weiler
  96. Evidence that the multiflorine‐derived substituted quinazolidine 55P0251 augments insulin secretion and lowers blood glucose via antagonism at α 2 ‐adrenoceptors in mice
  97. Response to: ‘The association between osteoporosis and statins therapy’ by Lai
  98. Diabetes und Schwangerschaft
  99. Diagnosis of osteoporosis in statin-treated patients is dose-dependent
  100. Insulin Clearance in Women with a History of Gestational Diabetes Assessed by Mathematical Model Analyses of Intravenous Glucose Tolerance Test
  101. Model-Based Assessment of Sex Differences in Glucose Effectiveness and Its Components
  102. Influence of Genotype and Hyperandrogenism on Sexual Function in Women With Congenital Adrenal Hyperplasia
  103. Identifying a disease-specific renin–angiotensin–aldosterone system fingerprint in patients with primary adrenal insufficiency
  104. Nutritional Lifestyle Intervention in Obese Pregnant Women, Including Lower Carbohydrate Intake, Is Associated With Increased Maternal Free Fatty Acids, 3-β-Hydroxybutyrate, and Fasting Glucose Concentrations: A Secondary Factorial Analysis of the Euro...
  105. Plasma renin levels are associated with cardiac function in primary adrenal insufficiency
  106. Diagnose und Management der Osteoporose bei Diabetes mellitus (Update 2019)
  107. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen (Update 2019)
  108. Glucose effectiveness and its components in relation to body mass index
  109. A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention
  110. Decreased beta-cell function in breastfeeding obese and non-obese women: A prospective observational study
  111. Gestational Diabetes Mellitus (GDM) – Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018)
  112. Sex- and age-related differences of metabolic parameters in impaired glucose metabolism and type 2 diabetes compared to normal glucose tolerance
  113. The MTNR1B rs10830963 Variant in Interaction with Pre-Pregnancy BMI is a Pharmacogenetic Marker for the Initiation of Antenatal Insulin Therapy in Gestational Diabetes Mellitus
  114. Sex-specific analysis of haemodialysis prevalence, practices and mortality over time: the Austrian Dialysis Registry from 1965 to 2014
  115. The wave of sweetness and obesity continues
  116. Association between Gestational Weight Gain, Gestational Diabetes Risk, and Obstetric Outcomes: A Randomized Controlled Trial Post Hoc Analysis
  117. Diabetes und Schwangerschaft
  118. Gestationsdiabetes mellitus (GDM), Diagnostik, Therapie und Nachsorge
  119. Pericardial Fat Relates to Disturbances of Glucose Metabolism in Women with the Polycystic Ovary Syndrome, but Not in Healthy Control Subjects
  120. Job-related meaningfulness moderates the association between over-commitment and emotional exhaustion in nurses
  121. Adiponectin and Leptin at Early Pregnancy: Association to Actual Glucose Disposal and Risk for GDM—A Prospective Cohort Study
  122. Risk factors for hyperglycemia in pregnancy in the DALI study differ by period of pregnancy and OGTT time point
  123. Needle beats pill in gestational diabetes mellitus
  124. Assessment of glucose effectiveness from short IVGTT in individuals with different degrees of glucose tolerance
  125. Management of Pregnant Women after Bariatric Surgery
  126. Sex and Gender Differences in Prevention of Type 2 Diabetes
  127. Cost-effectiveness of healthy eating and/or physical activity promotion in pregnant women at increased risk of gestational diabetes mellitus: economic evaluation alongside the DALI study, a European multicenter randomized controlled trial
  128. Accuracy, User Acceptability, and Safety Evaluation for the FreeStyle Libre Flash Glucose Monitoring System When Used by Pregnant Women with Diabetes
  129. Diabetes in pregnancy: a new decade of challenges ahead
  130. Combined Metabolomic Analysis of Plasma and Urine Reveals AHBA, Tryptophan and Serotonin Metabolism as Potential Risk Factors in Gestational Diabetes Mellitus (GDM)
  131. Correlates of poor mental health in early pregnancy in obese European women
  132. Assessment of glucose regulation in pregnancy after gastric bypass surgery
  133. Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients
  134. Is a motivational interviewing based lifestyle intervention for obese pregnant women across Europe implemented as planned? Process evaluation of the DALI study
  135. Sex and gender differences in therapy of type 2 diabetes
  136. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy
  137. Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults
  138. Influence of gender, working field and psychosocial factors on the vulnerability for burnout in mental hospital staff: results of an Austrian cross-sectional study
  139. Effects of age, gender, and body mass index on efficacy and hypoglycaemia outcomes across treat-to-target trials with insulin glargine 100 U/mL added to oral antidiabetes agents in type 2 diabetes
  140. Epidemiology of gestational diabetes mellitus according to IADPSG/WHO 2013 criteria among obese pregnant women in Europe
  141. Mann oder Frau: Ist das bei Diabetes relevant?
  142. The Fatty Liver Index (FLI) Relates to Diabetes-Specific Parameters and an Adverse Lipid Profile in a Cohort of Nondiabetic, Dyslipidemic Patients
  143. Similarities in trabecular hypertrophy with site-specific differences in cortical morphology between men and women with type 2 diabetes mellitus
  144. Impact of Diabetes Mellitus on Ischemic Events in Men and Women After Percutaneous Coronary Intervention
  145. Switch to Combined GLP1 Receptor Agonist Lixisenatide with Basal Insulin Glargine in Poorly Controlled T2DM Patients with Premixed Insulin Therapy: A Clinical Observation and Pilot Study in Nine Patients
  146. Microvascular function in women with former gestational diabetes: A cohort study
  147. Association Study with 77 SNPs Confirms the Robust Role for the rs10830963/G of MTNR1B Variant and Identifies Two Novel Associations in Gestational Diabetes Mellitus Development
  148. Type 2 Diabetes and Cardiovascular Risk in Women 2016
  149. Effect of physical activity and/or healthy eating on GDM risk: The DALI Lifestyle Study
  150. Increased Proportion of Hematopoietic Stem and Progenitor Cell Population in Cord Blood of Neonates Born to Mothers with Gestational Diabetes Mellitus
  151. Better insight into gender-specific diabetes self-management for more effective diabetes services
  152. Use of statins offsets insulin-related cancer risk
  153. Gestationsdiabetes mellitus (GDM) –Diagnostik, Therapie und Nachsorge ,
  154. Diabetes und Schwangerschaft
  155. Altered glucose profiles and risk for hypoglycaemia during oral glucose tolerance testing in pregnancies after gastric bypass surgery
  156. Wie Gender in die Diabetes-Selbstmanagement-Applikation kommt – ein vielversprechender Weg
  157. Diabetes und Schwangerschaft
  158. To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS
  159. The impact of preconceptional obesity on trajectories of maternal lipids during gestation
  160. Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
  161. IADPSG and WHO 2013 Gestational Diabetes Mellitus Criteria Identify Obese Women With Marked Insulin Resistance in Early Pregnancy: Table 1
  162. Determinants of growth differentiation factor 15 in patients with stable and acute coronary artery disease. A prospective observational study
  163. Migration und Diabetes
  164. Psychische Erkrankungen und Diabetes mellitus
  165. Insulintherapie bei Diabetes mellitus
  166. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  167. Gestationsdiabetes (GDM)
  168. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  169. Insulinpumpentherapie bei Kindern, Jugendlichen und Erwachsenen
  170. Diabetische Nierenerkrankung – Update 2016
  171. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  172. Initial evidence for the link between activities and health: Associations between a balance of activities, functioning and serum levels of cytokines and C-reactive protein
  173. Brennpunkt Adipositas: what gender has to do with …!
  174. Sexualität bei Übergewicht und Adipositas
  175. Clinical and metabolic characteristics of treated hyperlipidemic patients additionally affected by subclinical hyperglycemia
  176. Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients
  177. Diabetes mellitus und Schwangerschaft
  178. The Cross-Link between Adipokines, Insulin Resistance and Obesity in Offspring of Diabetic Pregnancies
  179. Cardiometabolic Risk in Hyperlipidemic Men and Women
  180. Beliefs, Barriers, and Preferences of European Overweight Women to Adopt a Healthier Lifestyle in Pregnancy to Minimize Risk of Developing Gestational Diabetes Mellitus: An Explorative Study
  181. Gender Obesity Report – Einfluss von Adipositas auf Reproduktion und Schwangerschaft
  182. Human insulin dynamics in women: a physiologically based model
  183. Gender Awareness bei Medizinstudierenden der Medizinischen Universität Wien. Eine empirische Analyse von Geschlechtersensibilität und Geschlechterstereotypisierungen
  184. Application of Penalized Regression Techniques in Modelling Insulin Sensitivity by Correlated Metabolic Parameters
  185. Gender and heart disease
  186. Circulating Betatrophin Is Strongly Increased in Pregnancy and Gestational Diabetes Mellitus
  187. Potential of a Sports Club–Based Exercise Program for Improving Physical Activity in Type 2 Diabetes Mellitus
  188. Lactation and appetite-regulating hormones: increased maternal plasma peptide YY concentrations 3–6 months postpartum
  189. Physical activity, depressed mood and pregnancy worries in European obese pregnant women: results from the DALI study
  190. Results From a European Multicenter Randomized Trial of Physical Activity and/or Healthy Eating to Reduce the Risk of Gestational Diabetes Mellitus: The DALI Lifestyle Pilot
  191. Sex-related differences in baseline characteristics, management and outcome in patients with acute coronary syndrome without ST-segment elevation
  192. Diabetes in pregnancy outcomes: A systematic review and proposed codification of definitions
  193. To explain the variation of OGTT dynamics by biological mechanisms: a novel approach based on principal components analysis in women with history of GDM
  194. Quantification of Diabetes Comorbidity Risks across Life Using Nation-Wide Big Claims Data
  195. Gender-based differences in glycaemic control and hypoglycaemia prevalence in patients with type 2 diabetes: results from patient-level pooled data of six randomized controlled trials
  196. Pathophysiological Characteristics and Effects of Obesity in Women With Early and Late Manifestation of Gestational Diabetes Diagnosed by the International Association of Diabetes and Pregnancy Study Groups Criteria
  197. Contrast induced acute kidney injury in acute coronary syndrome patients: A single centre experience
  198. Do patient-reported outcome measures cover personal factors important to people with rheumatoid arthritis? A mixed methods design using the International Classification of Functioning, Disability and Health as frame of reference
  199. Cord serum dipeptidyl-peptidase 4 activity in gestational diabetes
  200. Diabetes mellitus und Schwangerschaft
  201. Type 2 Diabetes and Cardiovascular Risk in Women
  202. Hidden Metabolic Disturbances in Women with Normal Glucose Tolerance Five Years after Gestational Diabetes
  203. Iodine deficiency in pregnant women in Austria
  204. Sex-specific differences in diabetes prevention: a systematic review and meta-analysis
  205. No Evidence of Ectopic Lipid Accumulation in the Pathophysiology of the Acromegalic Cardiomyopathy
  206. Sex-Specific Differences in Hemodialysis Prevalence and Practices and the Male-to-Female Mortality Rate: The Dialysis Outcomes and Practice Patterns Study (DOPPS)
  207. Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus
  208. Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions
  209. Gendermedizin
  210. Gestational Diabetes Mellitus (GDM) Diagnosis, Therapy and Follow-Up Care
  211. Inhibition of 11β-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial
  212. Is early postpartum HbA1c an appropriate risk predictor after pregnancy with gestational diabetes mellitus?
  213. Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals
  214. Hepatic Rather Than Cardiac Steatosis Relates to Glucose Intolerance in Women with Prior Gestational Diabetes
  215. Predicting the Metabolic Condition After Gestational Diabetes Mellitus from Oral Glucose Tolerance Test Curves Shape
  216. Diabetes in Hyperparathyroidism
  217. Gestational diabetes mellitus and cardiovascular risk after pregnancy
  218. Effect of Fetal and Infant Malnutrition on Metabolism in Older Age
  219. Health determining concepts important to people with Crohn's disease and their coverage by patient-reported outcomes of health and wellbeing
  220. Typ-1-Diabetes
  221. Development of a new occupational balance-questionnaire: incorporating the perspectives of patients and healthy people in the design of a self-reported occupational balance outcome instrument
  222. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma
  223. Diabetologie kompakt
  224. Association of diabetes mellitus and metformin use with oncological outcomes of patients with non-muscle-invasive bladder cancer
  225. Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer
  226. Lower Fasting Muscle Mitochondrial Activity Relates to Hepatic Steatosis in Humans
  227. Impact of statin use on biochemical recurrence in patients treated with radical prostatectomy
  228. DALI: Vitamin D and lifestyle intervention for gestational diabetes mellitus (GDM) prevention: an European multicentre, randomised trial – study protocol
  229. Analysis of Intravenous Glucose Tolerance Test Data Using Parametric and Nonparametric Modeling: Application to a Population at Risk for Diabetes
  230. Geschlechtsspezifische Unterschiede der Endokrinologie im Alter
  231. Reply to Klitz and Niklasson: Can viral infections explain the cross-sectional Austrian diabetes data?
  232. Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century
  233. Relationship of pentraxin 3 with insulin sensitivity in gestational diabetes
  234. Nur „der kleine Unterschied“?
  235. Concentration of Free Amino Acids in Human Milk of Women with Gestational Diabetes Mellitus and Healthy Women
  236. Estimating the risk after gestational diabetes mellitus: can we improve the information from the postpartum OGTT?
  237. Lipoprotein(a) is not related to markers of insulin resistance in pregnancy
  238. Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study
  239. The impact of recurrent gestational diabetes on maternal metabolic and cardiovascular risk factors
  240. Migration und Diabetes
  241. Positionspapier: Psychische Erkrankungen und Diabetes mellitus
  242. Insulintherapie bei Diabetes mellitus
  243. Geschlechtsspezifische Aspekte für die klinische Praxis bei Prädiabetes und Diabetes mellitus
  244. Gravidität bei vorbestehendem Diabetes für die Leitlinien für die Praxis (AG Diabetes und Schwangerschaft der ÖDG)
  245. Gestationsdiabetes (GDM)
  246. Leitlinien Insulinpumpentherapie bei Kindern und Erwachsenen (Für den Ausschuss Insulinpumpentherapie der Österreichischen Diabetesgesellschaft)
  247. Antihyperglykämische Therapie bei Diabetes mellitus Typ 2
  248. Diabetische Nephropathie – Update 2012
  249. Retinal white blood cell flux and systemic blood pressure in patients with type 1 diabetes
  250. Progression to Type 2 Diabetes in Women with Former Gestational Diabetes: Time Trajectories of Metabolic Parameters
  251. Sex-specific differences in long-term glycemic control and cardiometabolic parameters in patients with type 1 diabetes treated at a tertiary care centre
  252. A two-step screening algorithm including fasting plasma glucose measurement and a risk estimation model is an accurate strategy for detecting gestational diabetes mellitus
  253. Obesity and Diabetes
  254. Adrenal Disorders
  255. Thyroid Disorders
  256. Challenges of Work–Life Balance for Women Physicians/Mothers Working in Leadership Positions
  257. CTX (Crosslaps) Rather than Osteopontin Is Associated with Disturbed Glucose Metabolism in Gestational Diabetes
  258. Fetuin-A and angiopoietins in obesity and type 2 diabetes mellitus
  259. Circulating progranulin levels in women with gestational diabetes mellitus and healthy controls during and after pregnancy
  260. Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review
  261. Associations of Body Mass Index (Maternal BMI) and Gestational Diabetes Mellitus with Neonatal and Maternal Pregnancy Outcomes in a Multicentre European Database (Diabetes and Pregnancy Vitamin D and Lifestyle Intervention for Gestational Diabetes Mel...
  262. Diabetic Polyneuropathy Relates to Bone Metabolism and Markers of Bone Turnover in Elderly Patients With Type 2 Diabetes: Greater Effects in Male Patients
  263. Women show a closer association between educational level and hypertension or diabetes mellitus than males: a secondary analysis from the Austrian HIS
  264. Evaluation of educational needs in patients with diabetes mellitus in respect of medication use in Austria
  265. Transcription factor 7-like 2 gene polymorphisms and gestational diabetes mellitus
  266. Levels of fetuin-A relate to the levels of bone turnover biomarkers in male and female patients with type 2 diabetes
  267. Comparison of HbA1c and oral glucose tolerance test for diagnosis of diabetes in patients with coronary artery disease
  268. Estimation of prehepatic insulin secretion: comparison between standardized C-peptide and insulin kinetic models
  269. Fatty Liver Index Predicts Further Metabolic Deteriorations in Women with Previous Gestational Diabetes
  270. Non-esterified fatty acid dynamics during oral glucose tolerance test in women with former gestational diabetes
  271. Influence of Increasing BMI on Insulin Sensitivity and Secretion in Normotolerant Men and Women of a Wide Age Span
  272. Characterization of Former Gestational Diabetes Mellitus: Prognostic, Therapeutic, and Predictive Aspects
  273. The Impact of Type 2 Diabetes on Circulating Adipokines in Patients with Metabolic Syndrome
  274. Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot Study
  275. Incretin Effect in Women with Former Gestational Diabetes within a Short Period after Delivery
  276. Gestational Diabetes Prediction Score (GPS): Eine kosteneffektive Möglichkeit zur Vorhersage von Gestationsdiabetes bei Schwangerschaften mit normalem Nüchternblutzucker
  277. Sex and Gender Differences in Endocrinology
  278. Diabetes und Schwangerschaft
  279. Impact of diabetes mellitus and gender on exercise-related antiangiogenic endostatin/collagen XVIII release
  280. Influence of age, smoking and T2 diabetes on exercise related antiangiogenic endostatin/collagen XVIII release in men
  281. Diabetes und Schwangerschaft
  282. Gestationsdiabetes mellitus (GDM)
  283. Gestationsdiabetes mellitus (GDM) - Diagnostik, Therapie u. Nachsorge
  284. Admission Proinsulin Is Associated with Mortality in Patients with Admission Hyperglycemia during Acute Coronary Syndrome: Results from a Pilot Observational Study
  285. Skeletal Muscle Phosphodiester Content Relates to Body Mass and Glycemic Control
  286. Early Possible Risk Factors for Overt Diabetes After Gestational Diabetes Mellitus
  287. Recruitment of patients with type 2 diabetes for target group specific exercise programs at an Outpatient Department of a Medical University: A factor analysis
  288. Glucose Absorption in Gestational Diabetes Mellitus During an Oral Glucose Tolerance Test
  289. Insulin resistance is not associated with myocardial steatosis in women
  290. Relations of Adiponectin to Levels of Metabolic Parameters and Sexual Hormones in Elderly Type 2 Diabetic Patients
  291. Clinical characteristics, modalities and complications of diabetic patients with migration background at a Central European University Clinic
  292. Editorial: Sex- and gender-based medicine: a challenging field of research
  293. Health behaviour and attitude towards screening examinations in an Austrian urban and rural population: gender aspects – screening and sex
  294. Identification of a model of non-esterified fatty acids dynamics through genetic algorithms: The case of women with a history of gestational diabetes
  295. Perspectives on gender-specific medicine, course and learning style preferences in medical education: a study among students at the Medical University of Vienna
  296. Mechanism and Effects of Glucose Absorption during an Oral Glucose Tolerance Test Among Females and Males
  297. Risk Factor Profile and Pregnancy Outcome in Women with Type 1 and Type 2 Diabetes Mellitus
  298. Coverage of recommended vaccinations in subjects with diabetes mellitus and ischemic heart disease: results for women and men
  299. Shape of glucose, insulin, C-peptide curves during a 3-h oral glucose tolerance test: any relationship with the degree of glucose tolerance?
  300. Diabetes mellitus und Schwangerschaft
  301. N-terminal-pro-brain natriuretic peptide is decreased in insulin dependent gestational diabetes mellitus: a prospective cohort trial
  302. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross-sectional study
  303. Plasma neuropeptide Y levels differ in distinct diabetic conditions
  304. Sex-Specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus
  305. Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus
  306. Body and Liver Fat Mass Rather Than Muscle Mitochondrial Function Determine Glucose Metabolism in Women With a History of Gestational Diabetes Mellitus
  307. Diabetes und Schwangerschaft
  308. Retinal Blood Flow in Type 1 Diabetic Patients With No or Mild Diabetic Retinopathy During Euglycemic Clamp
  309. Changes in Serum Lipid Levels During Pregnancy in Type 1 and Type 2 Diabetic Subjects
  310. Cross-sectional survey on thyroideal and gonadal hormones in adult patients with high-grade gliomas.
  311. Acht-wöchiges Bewegungsprogramm für Diabetiker verändert nachhaltig deren körperliche Aktivität
  312. Herzfunktion und myocardialer Lipidgehalt bei Frauen nach Gestationsdiabetes
  313. Science & gender: vision and mission
  314. Retinol-Binding Protein 4 in Patients with Gestational Diabetes Mellitus
  315. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy
  316. Antithrombotic therapy in patients with coronary artery disease and with type 2 diabetes mellitus
  317. Diabetes mellitus – Leitlinien für die Praxis
  318. Osteocalcin Is Related to Enhanced Insulin Secretion in Gestational Diabetes Mellitus
  319. Metabolic diseases and associated complications: sex and gender matter!
  320. Serum Vaspin Concentrations in Relation to Insulin Sensitivity Following RYGB-Induced Weight Loss
  321. TCF7L2– Polymorphismen und Gestationsdiabetes
  322. Faktorenanalyse bei Patienten mit Diabetes mellitus, die den Teilnahmewunsch an einem medizinischen Trainingsprogramm beeinflussen
  323. Veränderungen der körperlichen Aktivität im 6 Monate Follow-up in Folge eines 8-wöchigen Bewegungsprogramms
  324. Effects of T4 replacement therapy on glucose metabolism in subjects with subclinical (SH) and overt hypothyroidism (OH)
  325. Value of the intravenous and oral glucose tolerance tests for detecting subtle impairments in insulin sensitivity and beta-cell function in former gestational diabetes
  326. Plasma Osteopontin Increases After Bariatric Surgery and Correlates with Markers of Bone Turnover But Not with Insulin Resistance
  327. Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes
  328. The Impact of Risk Factors and More Stringent Diagnostic Criteria of Gestational Diabetes on Outcomes in Central European Women
  329. Retinol – bindendes Protein 4 bei Patientinnen mit Gestationsdiabetes
  330. Diabetes und Schwangerschaft
  331. Insulin resistance has no impact on ghrelin suppression in pregnancy
  332. Impaired vascular nitric oxide bioactivity in women with previous gestational diabetes
  333. Diabetes mellitus – Leitlinien für die Praxis
  334. Diabetes und Schwangerschaft
  335. Visfatin Response to Glucose Is Reduced in Women With Gestational Diabetes Mellitus
  336. Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus
  337. Improved usability of the minimal model of insulin sensitivity based on an automated approach and genetic algorithms for parameter estimation
  338. Impaired cardiac autonomic function in women with prior gestational diabetes mellitus
  339. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione
  340. Insulinogenic indices from insulin and C-peptide: Comparison of beta-cell function from OGTT and IVGTT
  341. Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes
  342. Impaired beta-cell function in lean normotolerant former gestational diabetic women
  343. Gestational diabetes mellitus is associated with increased C-reactive protein concentrations in the third but not second trimester
  344. Sind "Designer"-Insuline die "besseren" Insuline?
  345. Severe diabetic fetopathy despite strict metabolic control
  346. Large-for-gestational-age newborns in women with insulin-treated gestational diabetes under strict metabolic control
  347. Endocrine Changes in Diabetic Pregnancy
  348. Fetal Hyperinsulinism and Maternal One-Hour Postload Plasma Glucose Level
  349. Decreased plasma adiponectin concentrations in women with gestational diabetes mellitus
  350. Haptoglobin Phenotype and Gestational Diabetes
  351. 40th EASD Annual Meeting of the European Association for the Study of Diabetes
  352. Diabetes in der Schwangerschaft
  353. Diabetes in der Praxis
  354. Gestational Diabetes
  355. Mode of action of ipomoea batatas (caiapo) in type 2 diabetic patients
  356. Basal and dynamic proinsulin-insulin relationship to assess β-cell function during OGTT in metabolic disorders
  357. Diabetes-Screening in der Schwangerschaft
  358. Increased Intramyocellular Lipid Concentration Identifies Impaired Glucose Metabolism in Women With Previous Gestational Diabetes
  359. Circulating concentrations of asymmetrical dimethyl- L -arginine are increased in women with previous gestational diabetes
  360. Ocular hyperperfusion following onset of intensified insulin therapy is inversely correlated with plasma endothelin-1 in Type I diabetes
  361. Book reviews
  362. Increased plasma leptin in gestational diabetes
  363. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy
  364. Dexamethasone lowers circulating E-selectin and ICAM-1 in healthy men
  365. 35th Annual Meeting of the European Association for the Study of Diabetes
  366. Elevation of plasma leptin concentrations in obese hyperinsulinaemic hypothyroidism before and after treatment
  367. Ectopic thyroid gland simulating a submandibular tumor
  368. Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease
  369. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  370. Persistent Elevation and Metabolic Dependence of Circulating E-Selectin after Delivery in Women with Gestational Diabetes Mellitus
  371. Pronounced Insulin Resistance and Inadequate  -cell Secretion Characterize Lean Gestational Diabetes During and After Pregnancy
  372. Amylin: History and Overview
  373. Amylin Release During Oral Glucose Tolerance Test
  374. Elevated Islet Amyloid Pancreatic Polypeptide and Proinsulin in Lean Gestational Diabetes
  375. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes
  376. β-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects
  377. Integrated mathematical model to assess beta-cell activity during the oral glucose test
  378. Intravenous calcitriol normalizes insulin sensitivity in uremic patients
  379. Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study
  380. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
  381. Role of islet amyloid polypeptide secretion in insulin-resistant humans
  382. Long-term treatment with nifedipine reduces urinary albumin excretion and glomerular filtration rate in normotensive type 1 diabetic patients with microalbuminuria
  383. Hormonal and blood glucose responsiveness as an indicator of specific emotional arousal in type 1 diabetics
  384. Elevated hepatic insulin extraction in essential hypertension
  385. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans
  386. Colour doppler imaging of partial subclavian steal syndrome
  387. β-Cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects
  388. Insulin secretion, insulin sensitivity and hepatic insulin extraction in primary hyperparathyroidism before and after surgery
  389. Laboratory monitoring of thromboprophylaxis with low molecular weight and standard heparin
  390. Insulin Sensitivity, Secretion and Hepatic Extraction in Untreated Hypertensive Patients